[Therapeutic testing of Amynoral in respiratory allergy syndrome of children].
D000293:Adolescent; D001249:Asthma / Q000188:drug therapy; D002648:Child; D005260:Female; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D010879:Piperazines / Q000627:therapeutic use*; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use*; D012130:Respiratory Hypersensitivity / Q000188:drug therapy*; D013431:Sulfates / Q000627:therapeutic use; D013566:Sympathomimetics / Q000627:therapeutic use*
D006634:Histamine H1 Antagonists; D010879:Piperazines; D000644:Quaternary Ammonium Compounds; D013431:Sulfates; D013566:Sympathomimetics
Essai thérapeutique de l'Amynoral dans les syndromes allergiques respiratoires de l'enfant.